Washington, DC — Nonpartisan ethics watchdog American Oversight and the Lower Drug Prices Now coalition today filed four Freedom of Information Act (FOIA) requests with the Department of Health and Human Services (HHS) for information on the development of coronavirus vaccines and the agency’s plans for making vaccines available to the public.”

WASHINGTON — Today, the Lower Drug Prices Now coalition co-hosted a press call following Eli Lilly’s shareholder meeting and in advance of Gilead’s to demand that COVID treatments developed with taxpayer dollars be affordable and accessible to all. 

“This is great news. But based on Gilead’s record, we’re deeply concerned that they’ll use their monopoly control to price-gouge patients and make this potentially life-saving treatment unaffordable and inaccessible. Remdesivir was developed using tens of millions of taxpayer dollars, and should be made available at no additional cost.

…

Continue reading “Statement from Margarida Jorge, Campaign Director, Lower Drug Prices Now, on the news that early trials of Gilead’s Remdesivir have shown positive results”